Skip to main content
Top
Published in: Endocrine 2/2020

01-02-2020 | Cushing's Syndrome | Clinical Management of Endocrine Diseases

Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome

Authors: Luigi Di Filippo, Giordano Vitali, Gianluca Taccagni, Federica Pedica, Giulia Guaschino, Emanuele Bosi, Sabina Martinenghi

Published in: Endocrine | Issue 2/2020

Login to get access

Abstract

Neuroendocrine carcinomas of the cervix are very rare, accounting for only 1–2% of all cervical cancers and <1% of all neuroendocrine tumors. Small-cell carcinoma of the cervix is associated with poor prognosis, even in early stages. Despite their neuroendocrine origin, tumors presenting with syndromes due to secreted neuroendocrine hormones are extremely rare. To date, only seven cases of cervical small-cell carcinoma associated with Cushing’s syndrome due to ectopic ACTH secretion have been described. In most reports, Cushing’s syndrome associated with these tumors occurred only in association with liver or lung metastasis. Only one single case of primary uterine cervix carcinoma secreting enough ACTH to induce Cushing’s syndrome in the absence of metastatic disease has been described in 1994. Here, we describe a case of cervical small-cell carcinoma presenting with an acute onset of severe hypokalemia in Cushing’s syndrome without metastatic disease to distant organs.
Literature
1.
go back to reference J.G. Cohen, D.S. Kapp, J.Y. Shin et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am. J. Obstet. Gynecol. 203, 347.e1–347e.6 (2010)CrossRef J.G. Cohen, D.S. Kapp, J.Y. Shin et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am. J. Obstet. Gynecol. 203, 347.e1–347e.6 (2010)CrossRef
2.
go back to reference A.N. Viswanathan, M.T. Deavers, A. Jhingran et al. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol. Oncol. 93, 27–33 (2004)CrossRef A.N. Viswanathan, M.T. Deavers, A. Jhingran et al. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol. Oncol. 93, 27–33 (2004)CrossRef
3.
go back to reference A. Gadducci, S. Carinelli, G. Aletti, Neuroendocrine tumors of the uterine cervix: a therapeutic challenge for gynecologic oncologists. Gynecol. Oncol. 144(3), 637–646 (2017)CrossRef A. Gadducci, S. Carinelli, G. Aletti, Neuroendocrine tumors of the uterine cervix: a therapeutic challenge for gynecologic oncologists. Gynecol. Oncol. 144(3), 637–646 (2017)CrossRef
4.
go back to reference P.H. Wang, Y.C. Liu, C.R. Lai et al. Small cell carcinoma of the cervix: analysis of clinical and pathological findings. Eur. J. Gynaecol. Oncol. 19, 189–192 (1998)PubMed P.H. Wang, Y.C. Liu, C.R. Lai et al. Small cell carcinoma of the cervix: analysis of clinical and pathological findings. Eur. J. Gynaecol. Oncol. 19, 189–192 (1998)PubMed
5.
go back to reference J.M. Shane, F. Naftolin, Aberrant hormone activity by tumors of gynecologic importance. Am. J. Obstet. Gynecol. 121, 133–147 (1975)CrossRef J.M. Shane, F. Naftolin, Aberrant hormone activity by tumors of gynecologic importance. Am. J. Obstet. Gynecol. 121, 133–147 (1975)CrossRef
6.
go back to reference A. Hashi, T. Yasumizu, I. Yoda et al. A case of small cell carcinoma of the uterine cervix presenting Cushing’s syndrome. Gynecol. Oncol. 61, 427–431 (1996)CrossRef A. Hashi, T. Yasumizu, I. Yoda et al. A case of small cell carcinoma of the uterine cervix presenting Cushing’s syndrome. Gynecol. Oncol. 61, 427–431 (1996)CrossRef
7.
go back to reference K. Iemura, T. Sonoda, S. Hayakawa et al. Small cell carcinoma of the uterine cervix showing Cushing’s syndrome caused by ectopic adrenocorticotropin hormone production. Jpn J. Clin. Oncol. 21, 293–298 (1991)PubMed K. Iemura, T. Sonoda, S. Hayakawa et al. Small cell carcinoma of the uterine cervix showing Cushing’s syndrome caused by ectopic adrenocorticotropin hormone production. Jpn J. Clin. Oncol. 21, 293–298 (1991)PubMed
8.
go back to reference N. Barghouthi, J. Perini, J. Cheng, Ectopic adrenocorticotropic hormone production: a case of neuroendocrine cervical small cell carcinoma presenting as cushing syndrome. AACE Clin. Case Rep. 4(5), e367–e369 (2018).CrossRef N. Barghouthi, J. Perini, J. Cheng, Ectopic adrenocorticotropic hormone production: a case of neuroendocrine cervical small cell carcinoma presenting as cushing syndrome. AACE Clin. Case Rep. 4(5), e367–e369 (2018).CrossRef
9.
go back to reference A.M. Isidori, G.A. Kaltsas, C. Pozza et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. JCEM 91(2), 371–377 (2006).PubMed A.M. Isidori, G.A. Kaltsas, C. Pozza et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. JCEM 91(2), 371–377 (2006).PubMed
10.
go back to reference I. Ilias, D.J. Torpy, K. Pacak et al. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. JCEM 90(8), 4955–4962 (2005).PubMed I. Ilias, D.J. Torpy, K. Pacak et al. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. JCEM 90(8), 4955–4962 (2005).PubMed
Metadata
Title
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome
Authors
Luigi Di Filippo
Giordano Vitali
Gianluca Taccagni
Federica Pedica
Giulia Guaschino
Emanuele Bosi
Sabina Martinenghi
Publication date
01-02-2020
Publisher
Springer US
Published in
Endocrine / Issue 2/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02202-x

Other articles of this Issue 2/2020

Endocrine 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.